Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. NATIONAL STOCK EXCHANGE OF AUSTRALIA LIMITED
  5. IQX Limited
  6. Company
    IQX   AU000000IQX4

IQX LIMITED

(IQX)
End-of-day quote. End-of-day quote NATIONAL STOCK EXCHANGE OF AUSTRALIA LIMITED - 08/10
0.13 AUD   +85.71%
09/09IQX : Annual Report June 2021
PU
09/09IQX Limited Reports Earnings Results for the Full Year Ended June 30, 2021
CI
07/08IQX LIMITED (NSX : IQX) Portfolio Company Awarded $6.3M Federal Govt Grant
AQ
SummaryChartsNewsCompanyFinancials 
Business Summary
IQX Limited is an Australia-based investment funds management company specializing in the bioscience sector. The Company operates through two operating segments, financial services and office and shared services. The Company is engaged in investment activities and exploring investment opportunities primarily in Australian biotech and life science companies and other registered intellectual property. It is also engaged in underwriting primary and secondary capital raisings, and managing discretionary accounts. The Company's subsidiaries include iQX Capital Pty Ltd, iQX Investment Services Pty Ltd, Life Science Holdings Pty Ltd, iQ Capital Partners (No.1) Pty Ltd, iQ Series 8 Life Science (Global) LP, Neutron Investment Group Pty Ltd, Life Science Ventures (No.1) Pty Ltd, Prosoma Therapeutics (No.1) Pty Ltd, Prosoma Therapeutics (No.2) Pty Ltd, Prosoma Therapeutics (No.3) Pty Ltd, Prosoma Therapeutics (No.4) Pty Ltd, and Prosoma Therapeutics (No.5) Pty Ltd.
Sales per Business
2018
Office and Shared Services1.5588.1%
Fees - Financial Services0.2111.8%
AUD in Million
Sales per region
20172018Delta
Australia3.40100%1.7699.8% -48.24%
AUD in Million
Managers
Name Title Age Since
George Syrmalis, Dr. Chief Executive Officer & Executive Director 56 2014
John Stratilas Independent Non-Executive Director 49 2012
Members of the board
Name Title Age Since
Kosmas Dimitriou Chairman 40 2012
George Syrmalis, Dr. Chief Executive Officer & Executive Director 56 2014
John Stratilas Independent Non-Executive Director 49 2012
Peter Buchanan Simpson Non-Executive Director 67 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Company contact information
IQX Ltd.
85 Castlereagh Street
Level 9
Sydney, New South Wales (NSW) 2000

Phone : +61.2.8239.5400
Fax : +61.2.8362.9547
Web : http://www.iqxinvestments.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of iQX Limited
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
IQX LIMITED0.00%41
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420
PHARMARON BEIJING CO., LTD.83.56%25 755
ALNYLAM PHARMACEUTICALS, INC.46.45%22 621
HANGZHOU TIGERMED CONSULTING CO., LTD7.36%22 569
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.76.28%22 197
ICON PUBLIC LIMITED COMPANY37.55%21 371
BIO-TECHNE CORPORATION68.27%20 967
NOVAVAX, INC.113.02%17 693
INCYTE CORPORATION-12.64%16 781
PPD, INC.36.62%16 424
QIAGEN N.V.2.82%12 351
BACHEM HOLDING AG96.71%11 698
INTELLIA THERAPEUTICS, INC.189.14%11 559
PRA HEALTH SCIENCES, INC.0.00%10 965
SYNEOS HEALTH, INC.38.47%9 763
CRISPR THERAPEUTICS AG-18.67%9 489